GlassScriptPhysician profile
Michael Isam Balat
NPI 1558719658
$3,132.79
in general payments reported to CMS, 2019-2025
26 companies · $211 in 2025
The $211 reported for 2025 was more than what a typical Obstetrics provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $174 · 2020: $76.29 · 2021: $744 · 2022: $761 · 2023: $663 · 2024: $503 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,377.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,377.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $478.86 | 2023-2025 | Myfembree |
| Abbvie INC. | $427.61 | 2020-2023 | Orilissa |
| Pfizer INC. | $271.95 | 2021-2025 | |
| Myovant Sciences INC. | $243.72 | 2021-2022 | |
| Boston Scientific Corporation | $174.42 | 2019 | |
| Mayne Pharma Commercial LLC | $143.67 | 2021-2025 | |
| Coopersurgical, INC. | $139.77 | 2021-2025 | Sos |
| Caldera Medical, INC | $132.98 | 2023-2024 | Desara |
| Evofem Biosciences, INC. | $131.37 | 2021-2023 | Phexxi |
| Baxter Healthcare | $118.83 | 2023 | Floseal |
| Avion Pharmaceuticals | $93.38 | 2021-2022 | |
| Next Science LLC | $90.60 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $87.90 | 2021-2023 | |
| Organon LLC | $80.61 | 2021-2024 | |
| Hologic Sales and Service, LLC | $73.30 | 2021-2024 | Aptima, Thinprep 2000 Processor, Affirm Prone Biopsy System |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $66.78 | 2024-2025 | Zurzuvae |
| Astellas Pharma US INC | $65.33 | 2022-2024 | Veozah |
| Exeltis, USA INC. | $57.14 | 2020-2025 | Slynd |
| Innovation Technologies INC | $55.61 | 2024 | Irrisept |
| Agile Therapeutics, INC. | $52.43 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $34.69 | 2021-2022 | |
| Optumhealth Care Solutions, LLC | $33.64 | 2024 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Therapeuticsmd, INC. | $29.36 | 2020 | |
| Lilly USA, LLC | $18.11 | 2024 | Jardiance, Zepbound |
| Currax Pharmaceuticals LLC | $16.82 | 2025 | Contrave |
| Millicent US INC | $13.91 | 2023 | Intrarosa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Balat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.